The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts

Oncogene

Volumn 17, Issue 23, 1998, Pages 3007-3014

  Denissenko, Mikhail F ^a,c   Koudriakova, Tatiana B ^b,d   Smith, Leslie ^a   O'Connor, Timothy R ^a   Riggs, Arthur D ^a   Pfeifer, Gerd P ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c BD Technologies   (United States)

^d AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

Aflatoxin B1; Hepatocellular carcinoma; p53 gene

Indexed keywords

AFLATOXIN B1; PROTEIN P53;

ARTICLE; CODON; CONTROLLED STUDY; DNA ADDUCT; FOOD CONTAMINATION; GENE MUTATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

HEPATITIS B VIRUS;

EID: 0032506782     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202214     Document Type: Article

References (59)

1. Aguilar F, Harris CC, Sun T, Hollstein M and Cerutti P. (1994). Science, 264, 1317-1319.
2. Aguilar F, Hussain SP and Cerutti P. (1993). Proc. Natl. Acad. Sci. USA, 90, 8586-8590.
3. Bailey EA, Iyer RS, Stone MP, Harris TM and Essigmann JM. (1996). Proc. Natl. Acad. Sci. USA, 93, 1535-1539.
4. Benasutti M, Ejadi S, Whitlow MD and Loechler EL. (1988). Biochemistry, 27, 472-481.
5. Bressac B, Kew M, Wands J and Ozturk M. (1991). Nature, 350, 429-431.
6. Buetow KH, Sheffield VC, Zhu M, Zhou T, Shen FM, Hino O, Smith M, McMahon BJ, Lanier AP, London WT, Redeker A and Govindarajan S. (1992). Proc. Natl. Acad. Sci. USA, 89, 9622-9626.
7. Busby Jr. WF and Wogan GN. (1984). In Chemical Carcinogens Vol. 2. CE Searle (ed), American Chemical Society: Washington DC, pp. 945-1136.
8. Challen C, Lunec J, Warren W, Collier J and Bassendine MF. (1992). Hepatology, 16, 1362-1366.
9. Chetsanga CJ and Frenette GP. (1983). Carcinogenesis, 4, 997-1000.
10. Cho Y, Gorina S, Jeffrey P and Pavletich NP. (1994). Science, 265, 346-355.
11. Croy RG, Essigmann JM, Reinhold VN and Wogan GN. (1978). Proc. Natl. Acad. Sci. USA, 75, 1745-1749.
12. Croy RG and Wogan GN. (1981). Cancer Res., 41, 197-203.
13. D'Andrea AD and Haseltine WA. (1978). Proc. Natl. Acad. Sci. USA, 75, 4120-4124.
14. Denissenko MF, Chen JX, Tang MS and Pfeifer GP. (1997). Proc. Natl. Acad. Sci. USA, 94, 3893-3898.
15. Denissenko MF, Pao A, Pfeifer GP and Tang M-s. (1998). Oncogene, 16, 1241-1247.
16. Denissenko MF, Pao A, Tang M-s and Pfeifer GP. (1996). Science, 274, 430-432.
17. Duflot A, Hollstein M, Mehrotra R, Trepo C, Montesano R and Cova L. (1994). Carcinogenesis, 15, 1353-1357.
18. Eaton DL and Gallagher EP. (1994). Annu. Rev. Pharmacol. Toxicol., 34, 135-172.
19. Eisenstadt E, Warren AJ, Porter J, Atkins D and Miller JH. (1982). Proc. Natl. Acad. Sci. USA, 79, 1945-1949.
20. Essigmann JM, Croy RG, Bennett RA and Wogan GN. (1982). Drug Metab. Rev., 13, 581-602.
21. Essigmann JM, Croy RG, Nadzan AM, Busby Jr. WF, Reinhold VN, Buchi G and Wogan GN. (1977). Proc. Natl. Acad. Sci. USA, 74, 1870-1874.
22. Fujimoto Y, Hampton L, Luo L-d, Wirth PJ and Thorgeirsson SS. (1992). Cancer Res., 52, 1044-1046.
23. Greenblatt MS, Bennett WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855-4878.
24. Greenblatt MS, Feitelson MA, Zhu M, Bennett WP, Welsh JA, Jones R, Borkowski A and Harris CC. (1997). Cancer Res., 57, 426-432.
25. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC and Montesano R. (1998). Nucleic Acids Res., 26, 205-213.
26. Hayward NK, Walker GJ, Graham W and Cooksley E. (1991). Nature, 352, 764.
27. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC. (1991). Nature, 350, 427-428.
28. Hulla JE, Chen ZY and Eaton DL. (1993). Cancer Res., 53, 9-11.
29. Hussain SP, Aguilar F, Amstad P and Cerutti P. (1994). Oncogene, 9, 2277-2281.
30. Iatsimirskaia E, Tulebaev S, Storozhuk E, Utkin I, Smith D, Gerber N and Koudriakova T. (1997). Clin. Pharmacol. Ther., 61, 554-562.
31. Irvin TR and Wogan GN. (1985). Cancer Res., 45, 3497-3502.
32. Johnson WW, Harris TM and Guengerich FP. (1996). J. Am. Chem. Soc., 118, 8213-8220.
33. Kobertz WR, Wang D, Wogan GN and Essigmann JM. (1997). Proc. Natl. Acad. Sci. USA, 94, 9579-9584.
34. Komura JI and Riggs AD. (1998). Nucleic Acids Res., 26, 1807-1811.
35. Koudriakova T, Iatsimirskaia E, Tulebaev S, Spetie D, Utkin I, Mullet D, Thompson T, Vouros P and Gerber N. (1996). J. Pharmacol. Exp. Ther., 279, 1300-1309.
36. Kress S, Jahn UR, Buchmann A, Bannasch P and Schwarz M. (1992). Cancer Res., 52, 3220-3223.
37. Lasky T and Magder L. (1997). Environ. Health Perspect., 105, 392-397.
38. Leadon SA, Tyrrell RM and Cerutti PA. (1981). Cancer Res., 41, 5125-5129.
39. Lin JK, Miller JA and Miller EC. (1977). Cancer Res., 37, 4430-4438.
40. Mellon I, Spivak G and Hanawalt PC. (1987). Cell, 51, 241-249.
41. Muench KF, Misra RP and Humayun MZ. (1983). Proc. Natl. Acad. Sic. USA, 80, 6-10.
42. Murakami Y, Hayashi K, Hirohashi S and Sekiya T. (1991). Cancer Res., 51, 5520-5525.
43. Oda T, Tsuda H, Scarpa A, Sakamoto M and Hirohashi S. (1992). Cancer Res., 52, 6358-6364.
44. Oleykowski CA, Mayernik JA, Lim SE, Groopman JD, Grossman L, Wogan GN and Yeung AT. (1993). J. Biol. Chem., 268, 7990-8002.
45. Ozturk M Bressac B, Puisieux A, Kew M, Volkmann M, Bozcall S, Bella Mura J, de la Monte S, Carlson R, Blum H, Wands J, Takahashi H, von Weizsäcker F, Galun E, Kar S, Carr BI, Schröder CH, Erken E, Varinli S, Rustgi VK, Prat J, Toda G, Koch HK, Liang XH, Tang Z-Y, Shouval D, Lee H-S, Vyas GN, Sarosi I. (1991). Lancet, 338, 1356-1359.
46. Pfeifer GP, Drouin R, Riggs AD and Holmquist GP. (1991). Proc. Natl. Acad. Sci. USA, 88, 1374-1378.
47. Puisieux A, Lim S, Groopman J and Ozturk M. (1991). Cancer Res., 51, 6185-6189.
48. Refolo LM, Conley MP, Sambamurti K, Jacobsen JS and Humayun MZ. (1985). Proc. Natl. Acad. Sci. USA, 82, 3096-3100.
49. Rivkina MB, Cullen JM, Robinson WS and Marion PL. (1994). Cancer Res., 54, 5430-5437.
50. Rodriguez H, Drouin R, Holmquist GP, O'Connor TR, Boiteux S, Laval J, Doroshow JH and Akman SA. (1995). J. Biol. Chem., 270, 17633-17640.
51. Ross RK, Yuan J-M, Yu MC, Wogan GN, Qian G-S, Tu J-T, Groopman JD, Gao YT and Henderson BE. (1992). Lancet, 339, 943-946.
52. Sarasin AR, Smith CA and Hanawall PC. (1977). Cancer Res., 37, 1786-1793.
53. Shen H-M and Ong C-N. (1996). Mutat. Res., 366, 23-44.
54. Tommasi S, Denissenko MF and Pfeifer GP. (1997). Cancer Res., 57, 4727-4730.
55. Tornaletti S and Pfeifer GP. (1994). Science, 263, 1436-1438.
56. Tornaletti S and Pfeifer GP. (1996). In: Technologies for Detection of DNA Damage and Mutations GP Pfeifer (ed). Plenum Press: New York, pp. 199-209.
57. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA and Jay G. (1995). Nature Genet., 9, 41-47.
58. Unsal H, Yakicier C, Marcais C, Kew M, Volkmann M, Zentgraf H, Isselbacher KJ and Ozturk M. (1994). Proc. Natl. Acad. Sci. USA, 91, 822-826.
59. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE and Brash DE. (1993). Proc. Natl. Acad. Sci. USA, 90, 4216-4220.